文献速递慢性肾脏病肾血管病与高血压

慢性肾脏病患者尿素水平与心血管疾病

Urea levels and cardiovascular disease in patients with chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2022-02-26

CKD-REIN前瞻性队列纳入2507例未透析的肾脏科门诊CKD患者,按基线血清尿素水平分为三组(T1<10.5、T2 10.5–15.1、T3≥15.1 mmol/L),多因素调整后分析首次动脉粥样硬化性或非动脉粥样硬化性心血管事件及透析前全因死亡。结果显示T3组心血管事件风险高于T1组(HR 1.93),T3组透析前死亡风险亦升高(HR 1.73),提示尿素是超越包括eGFR在内心血管危险因素的心血管结局预测因子。

要点

  • T3组(尿素≥15.1 mmol/L)较T1组(<10.5 mmol/L)动脉粥样硬化性和非动脉粥样硬化性心血管事件风险升高,HR为1.93。
  • T3组透析前全因死亡风险较T1组升高,调整后HR为1.73;T2组为1.31,未达统计学显著。
  • 研究提示尿素是超越包括eGFR在内心血管危险因素的心血管结局预测因子。

核心结论

  • 研究数据提示,尿素是超越包括eGFR在内心血管危险因素的心血管结局预测因子。

研究设计与样本

  • CKD-REIN为前瞻性队列研究,纳入未接受维持性透析的肾脏科门诊CKD患者。
  • 分析共纳入2507例患者,按基线血清尿素水平分为三组:T1<10.5 mmol/L、T2 10.5–15.1 mmol/L、T3≥15.1 mmol/L。
  • 采用Cox比例风险模型估计首次动脉粥样硬化性或非动脉粥样硬化性心血管事件及透析前全因死亡的风险比(HR),模型调整基线合并症、实验室数据和用药。

主要发现

  • 2507例患者中位(四分位距)年龄为69(61–77)岁,平均(标准差)eGFR为33.5(11.6)mL/min/1.73 m²,54%有心血管疾病史。
  • 对包括eGFR在内的心血管危险因素多重调整后,T3组动脉粥样硬化性和非动脉粥样硬化性心血管事件风险高于T1组(事件数=451,HR[95%CI]:1.93[1.39–2.69])。
  • 透析前全因死亡(事件数=407)的调整后HR:T2组为1.31[0.97–1.76],T3组为1.73[1.22–2.45]。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated serum urea levels are common in moderate-to-advanced CKD. Several studies have shown that urea is a direct and indirect uremic toxin, especially with regard to cardiovascular disease. We sought to determine whether serum urea levels are associated with adverse cardiovascular events and death before renal replacement therapy (RRT) in patients with CKD. METHODS: CKD-REIN is a prospective cohort of CKD nephrology outpatients not receiving maintenance dialysis. The 2507 patients included in the analysis were divided into three groups according to the baseline serum urea level (T1 < 10.5, T2:10.5 to 15.1, and T3 ≥ 15.1 mmol/L). Cox proportional hazard models were used to estimate hazard ratios (HRs) for first atheromatous or nonatheromatous cardiovascular (CV) events, and all-cause mortality before RRT. The models were adjusted for baseline comorbidities, laboratory data, and medications. FINDINGS: Of the 2507 included patients (median [interquartile range (IQR)] age: 69[61-77]; mean (standard deviation) eGFR 33.5(11.6) mL/min/1.73 m²), 54% had a history of cardiovascular disease. After multiple adjustments for cardiovascular risk factors (including eGFR), patients in T3 had a higher risk of atheromatous and nonatheromatous cardiovascular events than patient in T1 (n events = 451, HR[95%CI]: 1.93[1.39-2.69]). The adjusted HRs for death before RRT (n events = 407) were 1.31[0.97; 1.76] and 1.73[1.22; 2.45] for patients T2 and those in T3, respectively. INTERPRETATION: Our data suggested that urea is a predictor of cardiovascular outcomes beyond CV risk factors including eGFR.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Laville SM, Couturier A, Lambert O, et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrol Dial Transplant. 2022. PMID: 35544273. doi:10.1093/ndt/gfac045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。